Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan · Delayed Price · Currency is TWD 46.10
-1.60 (-3.35%)
Mar 26, 2026, 1:30 PM CST
Orient EuroPharma Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -567.39 | -283.93 | 143.94 | -310.8 | 120.17 |
Depreciation & Amortization | 197.79 | 206.66 | 216.26 | 194.31 | 191.09 |
Loss (Gain) From Sale of Assets | -1.68 | 4.83 | -234.5 | -72.35 | -182.38 |
Asset Writedown & Restructuring Costs | 17.76 | - | - | 35.3 | 10 |
Loss (Gain) From Sale of Investments | - | -6.15 | - | - | - |
Loss (Gain) on Equity Investments | 61.01 | 27.29 | 18.27 | 30.14 | 19.14 |
Stock-Based Compensation | 0.64 | - | - | - | - |
Provision & Write-off of Bad Debts | 11.72 | 20.04 | 1.53 | -0.4 | -2.46 |
Other Operating Activities | 201.81 | 161.59 | 77 | 110.33 | -22.62 |
Change in Accounts Receivable | -3.36 | -130.38 | -14.93 | -112.85 | -60.86 |
Change in Inventory | -127.64 | -0.07 | 128.64 | -391.29 | 210.37 |
Change in Accounts Payable | -27.07 | -173.47 | -202.1 | 392.98 | -158.56 |
Change in Other Net Operating Assets | -55.81 | 52.48 | -69.44 | -94.12 | -46.25 |
Operating Cash Flow | -292.21 | -121.11 | 64.67 | -218.75 | 77.65 |
Operating Cash Flow Growth | - | - | - | - | -87.24% |
Capital Expenditures | -173.67 | -99.06 | -99.4 | -639.16 | -1,563 |
Sale of Property, Plant & Equipment | 4.03 | 2.9 | 424.44 | 101.91 | 216.12 |
Cash Acquisitions | -5.57 | - | - | - | - |
Sale (Purchase) of Intangibles | -14.97 | -1.15 | -1.3 | -1.93 | -5.05 |
Investment in Securities | 1,499 | 551.46 | -251.13 | -84.86 | -136.58 |
Other Investing Activities | -14.42 | 11.04 | -10.51 | 12.48 | -6.95 |
Investing Cash Flow | 1,295 | 465.2 | 62.11 | -611.56 | -1,495 |
Short-Term Debt Issued | - | - | 132.65 | 141.16 | 825.54 |
Long-Term Debt Issued | 574.41 | 354.17 | 154.15 | 701.57 | 1,251 |
Total Debt Issued | 574.41 | 354.17 | 286.79 | 842.72 | 2,076 |
Short-Term Debt Repaid | -394.15 | -211.6 | - | - | - |
Long-Term Debt Repaid | -1,129 | -737 | -481.06 | -322.9 | -275.5 |
Total Debt Repaid | -1,524 | -948.6 | -481.06 | -322.9 | -275.5 |
Net Debt Issued (Repaid) | -949.2 | -594.43 | -194.27 | 519.82 | 1,801 |
Common Dividends Paid | -101.04 | -86.75 | - | -73.74 | -130.12 |
Other Financing Activities | 566.94 | -79.74 | -15.44 | -17.78 | -311.13 |
Financing Cash Flow | -483.3 | -760.92 | -209.71 | 428.31 | 1,360 |
Foreign Exchange Rate Adjustments | -4.61 | 115.8 | 18.03 | 243.72 | -104.14 |
Net Cash Flow | 514.62 | -301.03 | -64.91 | -158.28 | -162.09 |
Free Cash Flow | -465.88 | -220.16 | -34.73 | -857.91 | -1,485 |
Free Cash Flow Margin | -10.14% | -5.01% | -0.76% | -18.14% | -31.16% |
Free Cash Flow Per Share | -5.37 | -2.54 | -0.40 | -9.89 | -17.08 |
Cash Interest Paid | 74.12 | 110.13 | 104.9 | 66.9 | 37.17 |
Cash Income Tax Paid | 27.52 | 151.13 | 21.75 | 21.75 | 60.83 |
Levered Free Cash Flow | 3.59 | -296.15 | -59.1 | -713.27 | -1,456 |
Unlevered Free Cash Flow | 49.88 | -229.13 | 7.21 | -669.81 | -1,432 |
Change in Working Capital | -213.87 | -251.44 | -157.83 | -205.29 | -55.29 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.